4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001615774-16-005207
Options or other derivatives
- Chief Executive Officer acquired 1,000,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Carpenter George C IV Chief Executive Officer | 2016-05-04 | Grant or award · 5% Secured Convertible Note due December 2017 | +0 | D | |||
| Carpenter George C IV Chief Executive Officer | 2016-05-04 | Grant or award · Common Stock Warrant | +1,000,000 | 1,000,000 | D | ||
Loading xslF345X03/s103156_form4.xml…